Human papillomavirus E6/7 specific T-cell responses among Asian individuals with cutaneous squamous cell carcinoma.
5 affiliations
- 1Department of Dermatology, Singapore General Hospital, Singapore.
- 2Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore.
- 3Agency for Science, Technology and Research, Singapore.
- 4Health Services Research Unit, Singapore General Hospital, Singapore.
- 5Department of Clinical Translational Research, Singapore General Hospital, Singapore.
Abstract
Cutaneous human papillomavirus (HPV)-specific cell-mediated immunity in patients with cutaneous squamous cell carcinoma (SCC) remains poorly understood, particularly in organ transplant recipients (OTRs), who often develop multiple viral warts and SCC under long-term immunosuppression. This study characterized HPV E6/E7-specific T-cell responses in OTRs with SCC and compared them with immunocompetent individuals with SCC. Participants were recruited in Singapore and included OTRs with a history of posttransplant primary SCC (n = 28) and immunocompetent individuals with SCC (n = 10). Fifteen-mer peptides spanning the E6/E7 regions of HPV8, HPV17, HPV49, and HPV98 were synthesized, and HPV-specific T-cell responses were measured using an enzyme-linked immune absorbent spot assay. Most participants showed positive responses to cytomegalovirus peptide, the positive control, with response rates of 82% in OTRs and 70% in immunocompetent participants. Among OTRs, 28.57% responded to HPV17 E6/E7 peptides and 14.29% to HPV98, while responses to HPV8 and HPV49 were lower (7.14% and 3.57%, respectively). In immunocompetent participants, 20% responded to HPV17 and HPV49, 10% to HPV8, and none to HPV98. This study provides preliminary evidence that circulating T cells reactive to selected β-HPV E6/E7 peptide pools can be detected in a subset of Asian participants with cutaneous SCC, including OTRs.
Related
- Programmed cell death ligand 2 (PD-L2) expression is inversely correlated with human papillomavirus status in oropharyngeal squamous cell carcinoma (OPSCC) tumors.
- Eyelid Cutaneous Metastasis of Parotid Gland Ductal Carcinoma.
- Bladder Urothelial Carcinoma Diagnosed by Perineal Cutaneous Biopsy: A Case Report
- Health beliefs and parental responses to human papillomavirus vaccination in the Middle East: a theory-informed narrative synthesis guided by the health belief model
- Delayed sequential lung, acral cutaneous and brain metastases after radical nephrectomy for clear cell renal cell carcinoma: a case report
BibTeX
@article{oh2026human,
title = {{Human papillomavirus E6/7 specific T-cell responses among Asian individuals with cutaneous squamous cell carcinoma.}},
author = {Choon C Oh and Christine Tham and Noor Z Hamis and Yan S Leong and Gek H Lim and Eng E Ooi},
journal = {JID innovations : skin science from molecules to population health},
year = {2026},
month = aug,
doi = {10.1016/j.xjidi.2026.100526},
url = {https://europepmc.org/article/MED/42927223},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Human papillomavirus E6/7 specific T-cell responses among Asian individuals with cutaneous squamous cell carcinoma.
AU - Choon C Oh
AU - Christine Tham
AU - Noor Z Hamis
AU - Yan S Leong
AU - Gek H Lim
AU - Eng E Ooi
PY - 2026
DA - 2026/08/13
JO - JID innovations : skin science from molecules to population health
DO - 10.1016/j.xjidi.2026.100526
UR - https://europepmc.org/article/MED/42927223
AB - Cutaneous human papillomavirus (HPV)-specific cell-mediated immunity in patients with cutaneous squamous cell carcinoma (SCC) remains poorly understood, particularly in organ transplant recipients (OTRs), who often develop multiple viral warts and SCC under long-term immunosuppression. This study characterized HPV E6/E7-specific T-cell responses in OTRs with SCC and compared them with immunocompetent individuals with SCC. Participants were recruited in Singapore and included OTRs with a history of posttransplant primary SCC (n = 28) and immunocompetent individuals with SCC (n = 10). Fifteen-mer peptides spanning the E6/E7 regions of HPV8, HPV17, HPV49, and HPV98 were synthesized, and HPV-specific T-cell responses were measured using an enzyme-linked immune absorbent spot assay. Most participants showed positive responses to cytomegalovirus peptide, the positive control, with response rates of 82% in OTRs and 70% in immunocompetent participants. Among OTRs, 28.57% responded to HPV17 E6/E7 peptides and 14.29% to HPV98, while responses to HPV8 and HPV49 were lower (7.14% and 3.57%, respectively). In immunocompetent participants, 20% responded to HPV17 and HPV49, 10% to HPV8, and none to HPV98. This study provides preliminary evidence that circulating T cells reactive to selected β-HPV E6/E7 peptide pools can be detected in a subset of Asian participants with cutaneous SCC, including OTRs.
SN - 2667-0267
ER -